Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$63,121,000
-$28,667,000 QoQ
Shares Held
850,000
-29.2% QoQ
Ownership
0.434%
of shares outstanding
% of Portfolio
3.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$13,945,760
PutShares
810,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cormorant Asset Management, LP holds $1,914,987,088 across 43 Biotechnology names. BBIO ranks #12 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
885,500 | $285,299,245 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $160,013,416 | |
| 3 | EYPT |
EyePoint, Inc.
|
8,265,000 | $106,535,850 | |
| 4 | EWTX |
Edgewise Therapeutics, Inc.
|
3,260,000 | $102,690,000 | |
| 5 | ERAS |
Erasca, Inc.
|
5,800,000 | $93,844,000 | |
| 6 | RAPP |
Rapport Therapeutics, Inc.
|
2,957,521 | $92,540,832 | |
| 7 | ALMS |
Alumis Inc.
|
3,949,241 | $87,001,779 | |
| 8 | ABVX |
Abivax S.A.
|
760,000 | $84,626,000 |
All Filings in BBIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,121,000 | 850,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $91,788,000 | 1,200,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $72,716,000 | 1,400,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $69,088,000 | 1,600,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $69,140,000 | 2,000,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $43,904,000 | 1,600,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $47,313,616 | 1,858,351 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,072,030 | 1,858,351 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $99,037,656 | 3,203,029 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $135,004,506 | 3,344,179 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $122,950,916 | 4,662,530 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $71,709,878 | 4,169,179 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $13,945,760 | 810,800 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $75,561,924 | 4,557,414 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,433,143 | 1,369,179 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,603,639 | 1,469,179 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,340,145 | 1,469,179 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $15,924,426 | 1,568,909 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,837,402 | 1,668,909 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $82,908,764 | 1,768,909 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $114,664,540 | 1,880,980 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $133,604,794 | 2,168,909 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $161,118,335 | 2,265,762 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $85,011,390 | 2,265,762 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $84,484,748 | 2,590,762 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $85,550,000 | 2,950,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||